Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
177,400
-
Share change
-
-915,119
-
Total reported value
-
$263,585
-
Price per share
-
$1.48
-
Number of holders
-
11
-
Value change
-
-$1,105,838
-
Number of buys
-
4
-
Number of sells
-
5
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q3 2017
As of 30 Sep 2017,
Aptose Biosciences Inc. - Common Shares was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
177,400 shares.
The largest 10 holders included
MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, US BANCORP \DE\, ROYAL BANK OF CANADA, BANK OF MONTREAL /CAN/, JANE STREET GROUP, LLC, ACADIAN ASSET MANAGEMENT LLC, Federation des caisses Desjardins du Quebec, UBS Group AG, and Tower Research Capital LLC (TRC).
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.